A multicenter pilot study examining the role of Circulating Tumor Cells (CTCs) as a blood-based tumor marker in patients with extensive small cell lung cancer (EX-SCLC)

A multicenter pilot study examining the role of Circulating Tumor Cells (CTCs) as a blood-based tumor marker in patients with extensive small cell lung cancer (EX-SCLC)

Abstract Background: SCLC, a variant of lung cancer marked by early metastases, accounts for 13% of all lung cancers diagnosed in US. Despite high response rates to treatment, it is an aggressive disease with a median survival of 9-11 months for patients with EX-SCLC. Detection of CTCs is a novel l...

Full description

Bibliographic Details
Main Authors: Chao H Huang, Jo eWick, Gurusingham (Sitta) eSittampalam, Victor Sanjit eNirmalanandhan, Apar eGanti, Stephen K Williamson, Prakash C Neupane, Andrew eGodwin, Sarah eSchmitt, Nora J Smart, Sarah eSpencer, Peter J Van Veldhuizen
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-10-01
Series:Frontiers in Oncology
Subjects:
Small Cell Lung Carcinoma
biomarkers
prognosis
circulating tumor cells
extensive stage
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00271/full

Internet

http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00271/full

Similar Items